CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Brasil Pharma SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Brasil Pharma SA
R Dos Pinheiros. 498 - 9 Andar
Phone: +55 1121175200p:+55 1121175200 Sao Paulo, 05.422-902  Brazil Fax: +55 1121175290f:+55 1121175290

Filed for Bankruptcy on 1/10/2018
On 1/10/2018, Brasil Pharma SA filed an application for Judicial Recovery Proceedings with the Court in Sao Paulo, Brazil. Included in the Group filing were: Drogarias Farmais S.A, Farmais Produtos S.A, Drogaria Amarilis S.A, Sant’ana S.A Drogaria Farmácias, Distribuidora Big Benn S.A, Rede Nordeste de Farmácias S.A, Nex Distribuidora de Produtos Farmacêuticos S.A, Brasil Pharma Promotora de Vendas Ltda, and Brasil Pharma Fidelidade Ltda.
On 6/6/2019, Brasil Pharma SA filed a motion to convert its Judicial Recovery Proceedings to Bankruptcy Proceedings as it has been unable to formulate a viable restructuring plan. The Sao Paulo Court appointed Deloitte Touche Tohmatsu Consultores as the Judicial Administrator of Brasil Pharma.
This company is no longer actively traded on any major stock exchange.

Business Summary
Brasil Pharma SA is a Brazil-based company engaged primarily in the pharmaceutical retail sector. The Company’s main business activity is selling medicine, perfumeries, cosmetics, dermocosmetics, personal care and beauty products in retail. The Company’s operations are divided into own transactions and franchise chain transactions. Its own transactions include 132 stores under the Drogaria Rosario Distrital trademark (Mid West), 38 stores under the Farmacias Guararapes trademark (Northeast), 210 stores under the Mais Economica trademark (South), 210 stores under the Big Benn trademark (North and Northeast) and 118 stores under the Sant’ana trademark (Northeast). Its Franchise chain transactions operate under the Farmais trademark with 388 stores, mostly located in the southern region of Brazil, in which Sao Paulo is the most representative state, with approximately 222 stores. The Company’s subsidiaries include, among others, Drogaria Rosario SA and Drogaria Guararapes Brasil SA.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes-Yes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201912/31/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Carlos DanielRizzo da Fonseca 39 5/6/2011 5/6/2011
Chief Executive Officer PauloGualtieri 55 3/25/2015 3/25/2015
Vice Chairman of the Board RobertoMartins de Souza 51 5/6/2011 5/6/2011
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Distribuidora Big Benn S/A Av. Alm Barroso, 5447 Altos Belem Para Brazil

Business Names
Business Name
BPHA3
Brasil Pharma Fidelidade Ltda.
Brasil Pharma Promotora de Vendas Ltda
17 additional Business Names available in full report.

General Information
Number of Employees: 15,191 (As of 3/31/2012)
Outstanding Shares: 113,081,127 (As of 3/31/2019)
Stock Exchange: SAO
Fax Number: +55 1121175290


Copyright © 2022 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, January 9, 2022